Name | GLPG-3221 |
---|
Description | GLPG-3221 is a potent, orally active corrector of CFTR (cystic fibrosis transmembrane conductance regulator), with an EC50 of 105 nM. GLPG-3221 can be uesd for the treatment of cystic fibrosis[1]. |
---|---|
Related Catalog | |
In Vivo | GLPG-3221 (1 mg/kg; i.v.) treatment shows the Cl and t1/2 are 0.13 L/h/kg and 3 hours, respectively[1]. GLPG-3221 (1 mg/kg; p.o.)treatment shows the F% value is 53%[1]. Animal Model: Rat[1] Dosage: 1 mg/kg Administration: i.v. administration (Pharmacokinetic Analysis) Result: The Cl and t1/2 were 0.13 L/h/kg and 3 hours, respectively. |
References |
Molecular Formula | C30H37F3N2O6 |
---|---|
Molecular Weight | 578.62 |